Search research articles
Contact Us
Filters
Showing results (311-320 of 347) with videos related to
Page
of 35
Sort By:
Frontiers in Immunology
|
April 17, 2020
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
Riccardo Scarpa, Federica Pulvirenti, Antonio Pecoraro, et al.
Frontiers in Immunology
|
July 31, 2025
Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol
Stefania Nicola, Marco Caminati, Richard Borrelli, et al.
European Journal of Internal Medicine
|
June 28, 2025
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study
Irene Mattioli, Michela Gasparotto, Alberto Bergamini, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target
Roberto Ria, Ivana Catacchio, Simona Berardi, et al.
Neoplasia (New York, N.Y.)
|
December 12, 2018
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Ilaria Saltarella, Maria Antonia Frassanito, Aurelia Lamanuzzi, et al.
The Journal of Pathology
|
August 1, 2012
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients
Antonio Basile, Michele Moschetta, Paolo Ditonno, et al.
Frontiers in Medicine
|
February 8, 2021
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
Antonio Giovanni Solimando, Nicola Susca, Paola Borrelli, et al.
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Ejhaem
|
October 17, 2024
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma
Stefan Knop, Monika Szarejko, Norbert Grząśko, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 347) with videos related to
Sort By:
Page
of 35
Frontiers in Immunology
|
April 17, 2020
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
Riccardo Scarpa, Federica Pulvirenti, Antonio Pecoraro, et al.
Frontiers in Immunology
|
July 31, 2025
Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol
Stefania Nicola, Marco Caminati, Richard Borrelli, et al.
European Journal of Internal Medicine
|
June 28, 2025
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study
Irene Mattioli, Michela Gasparotto, Alberto Bergamini, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target
Roberto Ria, Ivana Catacchio, Simona Berardi, et al.
Neoplasia (New York, N.Y.)
|
December 12, 2018
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Ilaria Saltarella, Maria Antonia Frassanito, Aurelia Lamanuzzi, et al.
The Journal of Pathology
|
August 1, 2012
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients
Antonio Basile, Michele Moschetta, Paolo Ditonno, et al.
Frontiers in Medicine
|
February 8, 2021
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
Antonio Giovanni Solimando, Nicola Susca, Paola Borrelli, et al.
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Ejhaem
|
October 17, 2024
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma
Stefan Knop, Monika Szarejko, Norbert Grząśko, et al.
Page
of 35